14-28768762-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_005249.5(FOXG1):c.*13C>A variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.017 in 1,613,930 control chromosomes in the GnomAD database, including 263 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 15 hom., cov: 32)
Exomes 𝑓: 0.017 ( 248 hom. )
Consequence
FOXG1
NM_005249.5 3_prime_UTR
NM_005249.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.58
Genes affected
FOXG1 (HGNC:3811): (forkhead box G1) This locus encodes a member of the fork-head transcription factor family. The encoded protein, which functions as a transcriptional repressor, is highly expressed in neural tissues during brain development. Mutations at this locus have been associated with Rett syndrome and a diverse spectrum of neurodevelopmental disorders defined as part of the FOXG1 syndrome. This gene is disregulated in many types of cancer and is the target of multiple microRNAs that regulate the proliferation of tumor cells. [provided by RefSeq, Jul 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 14-28768762-C-A is Benign according to our data. Variant chr14-28768762-C-A is described in ClinVar as [Benign]. Clinvar id is 95263.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-28768762-C-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0128 (1944/152174) while in subpopulation AMR AF= 0.0251 (383/15280). AF 95% confidence interval is 0.023. There are 15 homozygotes in gnomad4. There are 949 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1944 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FOXG1 | NM_005249.5 | c.*13C>A | 3_prime_UTR_variant | 1/1 | ENST00000313071.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FOXG1 | ENST00000313071.7 | c.*13C>A | 3_prime_UTR_variant | 1/1 | NM_005249.5 | P1 | |||
FOXG1 | ENST00000706482.1 | c.*13C>A | 3_prime_UTR_variant | 2/2 | P1 | ||||
LINC01551 | ENST00000675861.1 | n.374+2749C>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0128 AC: 1944AN: 152056Hom.: 15 Cov.: 32
GnomAD3 genomes
AF:
AC:
1944
AN:
152056
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0164 AC: 4120AN: 251124Hom.: 53 AF XY: 0.0152 AC XY: 2066AN XY: 135860
GnomAD3 exomes
AF:
AC:
4120
AN:
251124
Hom.:
AF XY:
AC XY:
2066
AN XY:
135860
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0174 AC: 25436AN: 1461756Hom.: 248 Cov.: 33 AF XY: 0.0169 AC XY: 12312AN XY: 727172
GnomAD4 exome
AF:
AC:
25436
AN:
1461756
Hom.:
Cov.:
33
AF XY:
AC XY:
12312
AN XY:
727172
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0128 AC: 1944AN: 152174Hom.: 15 Cov.: 32 AF XY: 0.0128 AC XY: 949AN XY: 74386
GnomAD4 genome
AF:
AC:
1944
AN:
152174
Hom.:
Cov.:
32
AF XY:
AC XY:
949
AN XY:
74386
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 04, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 01, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 17, 2012 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at